GRAIL to Announce Fourth Quarter 2024 Financial Results

Rhea-AI Summary

GRAIL (NASDAQ: GRAL) has announced it will release its fourth quarter 2024 financial results after market close on Thursday, February 20, 2025. The healthcare company, focused on early cancer detection, will follow the release with a management-hosted webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET.

The webcast will be accessible through GRAIL's investor relations website at investors.grail.com, with a recorded replay available afterward. Interested parties are advised to register at least ten minutes before the call's scheduled start time through the provided registration link.

News Market Reaction

+33.93%

1 alert

+33.93% News Effect

On the day this news was published, GRAL gained 33.93%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter 2024 following the close of market on Thursday, Feb. 20, 2025. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and business progress.

Fourth Quarter 2024 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.  

Please register for the live event at https://grail-q4-financial-results-2024.open-exchange.net/.

To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-fourth-quarter-2024-financial-results-302375079.html

SOURCE GRAIL, Inc.

FAQ

When will GRAIL (GRAL) release its Q4 2024 earnings?

GRAIL will release its Q4 2024 financial results after market close on Thursday, February 20, 2025.

What time is GRAIL's (GRAL) Q4 2024 earnings call?

GRAIL's Q4 2024 earnings conference call and webcast will be held at 1:30 p.m. PT / 4:30 p.m. ET on February 20, 2025.

How can investors access GRAIL's (GRAL) Q4 2024 earnings call?

Investors can access the live webcast through GRAIL's investor relations website at investors.grail.com or register for the teleconference at the provided registration link.

Will there be a replay available of GRAIL's (GRAL) Q4 2024 earnings call?

Yes, a recorded replay of the webcast will be available at the investor relations section of GRAIL's website at investors.grail.com.